Supply chain visibility and control key to building market share in pharma
Control and visibility are the two most vital aspects of a shipper’s pharma supply chain, ...
AMZN: APPEAL UPDATEDSV: PRESSURE BUILDS AAPL: OPENAI FUNDING INTERESTCHRW: ANOTHER INSIDER CASHES INHLAG: GRI DISCLOSUREMAERSK: HOVERING AROUND FOUR-MONTH LOWSTSLA: CHINA COMPETITIONDHL: BOLT-ON DEAL TALKAMZN: NEW ZEALAND PROJECTDHL: SURCHARGE RISKKNIN: LEGAL RISKF: 'DEI' HURDLESPLD: RATING UPDATEXOM: DISPOSALS
AMZN: APPEAL UPDATEDSV: PRESSURE BUILDS AAPL: OPENAI FUNDING INTERESTCHRW: ANOTHER INSIDER CASHES INHLAG: GRI DISCLOSUREMAERSK: HOVERING AROUND FOUR-MONTH LOWSTSLA: CHINA COMPETITIONDHL: BOLT-ON DEAL TALKAMZN: NEW ZEALAND PROJECTDHL: SURCHARGE RISKKNIN: LEGAL RISKF: 'DEI' HURDLESPLD: RATING UPDATEXOM: DISPOSALS
Schindellegi, CH, 4 January 2021
– Divestment of major part of the UK Contract Logistics portfolio successfully completed
– UK transaction follows recent divestments in France, Argentina
– Continued commitment to scalable Contract Logistics solutions worldwide, especially in e-commerce and pharma
With the completed divestment of a major part of its UK Contract Logistics portfolio to XPO Logistics, Kuehne+Nagel has completed the restructuring of this business unit. This transaction follows the sale of the Contract Logistics activities in Argentina, the chilled FMCG portfolio in France as well as a portfolio of real estate assets.
The UK transaction closes after the unconditional approval by the British Competition and Market Authority. The scope includes the drinks logistics, food services and retail & technology businesses. Kuehne+Nagel remains highly committed to excellent customer solutions and service in the UK.
Dr. Joerg Wolle, Chairman of Kuehne + Nagel International AG, says: “We initiated the strategic review of our Contract Logistics activities in the Board of Directors in early 2019 and informed our business partners and the public accordingly. With the divestment of parts of our contract logistics business in the UK, the focused, comprehensive restructuring process was successfully completed. The business unit is now well positioned to concentrate on scalable solutions worldwide, particularly in the e-commerce and pharmaceutical sectors.”
The deal was originally announced in early March 2020 and was expected to close in the second half of last year.
Comment on this article